Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafeBlood Technologies is a medical technology company specializing in autologous blood transfusion systems. The company's core technology, the SafeBlood system, allows for the collection, processing, and re-infusion of a patient's own blood during surgical procedures. This approach significantly reduces the need for allogeneic (donor) blood, thereby minimizing risks such as viral transmission, transfusion reactions, and post-operative infections. The system is designed for use in various surgical settings, including orthopedic, cardiovascular, and trauma surgeries. By prioritizing the use of the patient's own blood, the technology aims to improve patient outcomes and reduce healthcare costs associated with blood management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafeBlood Technologies.